Acetic Anhydride → HCID 70896273, compound
Reaction equation
[OH:1][CH2:2][C:3]1[CH:11]=[CH:10][C:9]2[CH2:12][NH:13][C@@H:14]([CH:17]3[CH:22]4[CH2:23][CH2:24][N:19]([CH2:20][CH2:21]4)[CH2:18]3)[C:15](=[O:16])[N:7]3[C:8]=2[C:4]=1[CH:5]=[CH:6]3.[C:25](OC(=O)C)(=[O:27])[CH3:26]>CN(C)C1C=CN=CC=1.N1C=CC=CC=1>[C:25]([O:1][CH2:2][C:3]1[CH:11]=[CH:10][C:9]2[CH2:12][NH:13][C@@H:14]([CH:17]3[CH:22]4[CH2:21][CH2:20][N:19]([CH2:24][CH2:23]4)[CH2:18]3)[C:15](=[O:16])[N:7]3[C:8]=2[C:4]=1[CH:5]=[CH:6]3)(=[O:27])[CH3:26]Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
4-(Dimethylamino)pyridine (13 mg, 0.05 mmol) was added to a solution of (S)-7-(hydroxymethyl)-2-(quinuclidin-3-yl)-3,4-dihydro-[1,4]diazepino[6,7,1-hi]indol-1(2H)-one from Step B above in a mixture of acetic anhydride (0.1 ml, 1.2 mmol) and pyridine (3 ml). The mixture was stirred overnight at room temperature, the solvent was removed under reduced pressure, and the residue was purified by column chromatography (silica gel, 90:10:1 methylene chloride/methanol/concentrated ammonium hydroxide) to afford (S)-(1-oxo-2-(quinuclidin-3-yl)-1,2,3,4-tetrahydro-[1,4]diazepino[6,7,1-hi]indol-7-yl)methyl acetate (124 mg, 71%) as a white solid: MS (ESI+) m/z 368 (M+H).
Workup
- customthe solvent was removed under reduced pressure
- customthe residue was purified by column chromatography (silica gel, 90:10:1 methylene chloride/methanol/concentrated ammonium hydroxide)
Sources & evidence
- ORD record
- ord-72b7c1cb4aee4903b13a183f12f129ff
- Source dataset
- uspto-grants-2014_04
- Patent number
- US08710046B2
Reaction notes
Loading…